Covestor

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
2,847
Total Value
146983
Accession Number
0001909846-25-000002
Form Type
13F-HR
Manager Name
Covestor
Data Enrichment
93% identified
2,661 identified186 unidentified

Holdings

2,847 positions • $147.0K total value
Manager:
Search and click to pin securities to the top
Page 141 of 141
Phathom Pharmaceuticals, Inc.
Shares:7
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
PLIANT THERAPEUTICS, INC.
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
PROTHENA CORP PUBLIC LTD CO
Shares:4
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Relay Therapeutics, Inc.
Shares:26
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Replimune Group, Inc.
Shares:11
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
RHYTHM PHARMACEUTICALS, INC.
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Core Laboratories Inc. /DE/
Shares:6
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
SpringWorks Therapeutics, Inc.
Shares:10
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Sana Biotechnology, Inc.
Shares:28
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Scilex Holding Co
Shares:3
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
SKYWEST INC
Shares:2
Value:$0
% of Portfolio:0.0% ($0/$147.0K)
Simulations Plus, Inc.
Shares:17
Value:$0
% of Portfolio:0.0% ($0/$147.0K)